Chen Cao
Tianjin, 300072, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
A hypoxia-responsive nanomedicine for cancer immunotherapy through ligand competition-induced dual-prodrug activation.
Journal: Journal of colloid and interface science
Published: June 17, 2025
Histone deacetylase inhibiting nanoprodrugs for enhanced chemodynamic therapy through multistage downregulating glutathione.
Journal: International journal of biological macromolecules
Published: December 02, 2024
Bifunctional cascaded single-atom nanozymes for enhanced photodynamic immunotherapy through dual-depressing PD-L1 and regulating hypoxia.
Journal: Biomaterials
Published: September 18, 2024
Dual-enzyme inhibiting nanomedicines for enhanced cancer chemodynamic therapy by inducing intratumoral acidosis.
Journal: International journal of pharmaceutics
Published: May 31, 2024
NQO1-activated multifunctional theranostic probe for imaging-guided mitochondria-targeted photodynamic therapy and boosting immunogenic cell death.
Journal: Talanta
Published: November 15, 2023
Clinical Features of Patients with Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease and Isolated Seizure Symptoms.
Journal: Neuropsychiatric disease and treatment
Published: October 26, 2023
Gas-assisted phototherapy for cancer treatment.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: March 05, 2023
Dual-prodrug cascade activation for chemo/chemodynamic mutually beneficial combination cancer therapy.
Journal: Biomaterials science
Published: December 23, 2022
Ability of weakly supervised learning to detect acute ischemic stroke and hemorrhagic infarction lesions with diffusion-weighted imaging.
Journal: Quantitative imaging in medicine and surgery
Published: March 23, 2021
Showing 1-9 of 9
Last Updated: 09/26/2026